Register Cart 0

Generic placeholder image

Letters in Drug Design & Discovery

Editor-in-Chief

ISSN (Print): 1570-1808
ISSN (Online): 1875-628X

Back Subscribe

Biography

Meet Our Editorial Board Member

Author(s): Dominique Heymann

Volume 16, Issue 8, 2019

Page: [825 - 825] Pages: 1

DOI: 10.2174/157018081608190712100045

Next »

Rights & Permissions Print Cite

Article Metrics

12

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Perspectives of Fullerenes, Dendrimers, and Heterocyclic Compounds Application in Tumor Treatment
Recent Patents on Nanomedicine

rDNA Mediated Bioconjugates: Fusion Proteins and their Intended Use in Medicine
Current Topics in Medicinal Chemistry

Tumor-Targeting Peptides and Small Molecules as Anti-Cancer Agents to Overcome Drug Resistance
Current Medicinal Chemistry

Exploring the Mitochondrial Apoptotic Cell Death Landscape and Associated Components Serving as Molecular Targets, Primarily for Synthetic and Natural Drugs Targeting Oncology Therapeutics
Current Molecular Pharmacology

New Developments and Prospective Applications for β (1,3) Glucans
Recent Patents on Biotechnology

First Mariner Mos1 Transposase Inhibitors (Supplementary Data)
Mini-Reviews in Medicinal Chemistry

Melanoma Immunotherapy: Past, Present, and Future
Current Pharmaceutical Design

Individualized Treatment Planning in Oncology: Role of PET and Radiolabelled Anticancer Drugs in Predicting Tumour Resistance
Current Pharmaceutical Design

Microenvironmental Regulation of Cancer Stem Cell Phenotypes
Current Stem Cell Research & Therapy

Parthenogenetic Cell Lines: An Unstable Equilibrium Between Pluripotency and Malignant Transformation
Current Pharmaceutical Biotechnology

Nanoparticles in Cancer
Current Radiopharmaceuticals

Adenoviral Vector-Mediated Gene Transfer for Human Gene Therapy
Current Gene Therapy

Monofunctional Platinum (PtII) Compounds – Shifting the Paradigm in Designing New Pt-based Anticancer Agents
Current Medicinal Chemistry

ING Proteins in Cellular Senescence
Current Drug Targets

Galectins: Major Signaling Modulators Inside and Outside the Cell
Current Molecular Medicine

Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments
Current Medicinal Chemistry

Adrenomedullin and Nitric Oxide: Implications for the Etiology and Treatment of Primary Brain Tumors
CNS & Neurological Disorders - Drug Targets

Patenting Networking and Knowledge Translation in Liposomes for Cancer Therapy
Recent Patents on Nanomedicine

Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain Pathways
Current Neuropharmacology

Tetherin Antagonism by Primate Lentiviral Nef Proteins
Current HIV Research

© 2024 Bentham Science Publishers | Privacy Policy